Molecular Fingerprinting of Lung Cancer
Summary
RATIONALE: Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that may occur in RNA and identify biomarkers related to cancer. PURPOSE: This research study is collecting and analyzing lung tissue samples from patients undergoing surgery for non-small cell lung cancer.
Detailed description
OBJECTIVES: * Develop statistical and computational methods for modeling the relationships between multiple variable protein and RNA expression data and clinical endpoints using both supervised and unsupervised classification and pattern recognition approaches. * Determine protein and RNA expression fingerprints on completely resected non-small cell lung cancer without prior chemotherapy. * Correlate protein and RNA expression fingerprints with T-stage and nodal involvement at the time of surgery, and collect outcome data to allow correlation with recurrence (local and/or distant) and survival. OUTLINE: This is a multicenter study. Any excess tissues removed from surgery and would otherwise be discarded (tissues not used for diagnosis and/or treatment decision making) are obtained for this study. Tissue are analyzed for molecular features that predict biologic behavior. Quantitation of RNA, gene expression profiles, and protein expression patterns are assessed by matrix-assisted laser desorption/ionization time of flight mass spectroscopy and microarray analysis. Medical records are reviewed to obtain information about results of tests associated with cancer diagnosis. Further progress in cancer treatment and tumor behavior after surgery are followed via record review.
Arms & interventions
- Geneticgene expression analysis
Blood and lung tissue collection
- Geneticmicroarray analysis
Blood and lung tissue collection
- Geneticprotein expression analysis
Blood and lung tissue collection
- Otherbiologic sample preservation procedure
Blood and lung tissue collection
- Otherlaboratory biomarker analysis
Blood and lung tissue collection
- Othermatrix-assisted laser desorption/ionization time of flight mass spectrometry
Blood and lung tissue collection
Outcome measures
Primary
Protein and RNA expression fingerprints from collected samples
Time frame: after collection of designated samples
Secondary
Development of statistical and computational methods to model relationship of data and clinical outcomes
Time frame: after laboratory gene analysis work is completed
Correlation of protein and RNA expression fingerprints with recurrence (local and/or distant) and survival
Time frame: after collection of designated samples
Eligibility criteria
Study locations (3)
Dan Rudy Cancer Center at Saint Thomas Hospital
Nashville, Tennessee, 37205
Veterans Affairs Medical Center - Nashville
Nashville, Tennessee, 37212
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, 37232-6838